What are the latest treatment options for Colorectal Cancer

Q: What are the latest treatment options for Colorectal Cancer

According to the NCCN National Comprehensive Cancer Network Guidelines for Colorectal Cancer, the main treatment options include: 1. Surgery - Primary treatment for early-stage disease - Different surgical approaches depending on tumor location and stage - May be minimally invasive when appropriate 2. Chemotherapy - Common regimens include: • FOLFOX 5-FU, leucovorin, and oxaliplatin • FOLFIRI 5-FU, leucovorin, and irinotecan • CAPOX capecitabine and oxaliplatin 3. Targeted Therapy The American S

Colorectal CancerOctober 15, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Grounded in NCCN Guidelines for Patients: Colon Cancer — the same guidelines oncologists use.
Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated October 15, 2025. Informational only — not a substitute for your oncology team.

According to the NCCN (National Comprehensive Cancer Network) Guidelines for Colorectal Cancer, the main treatment options include:

Surgery

Primary treatment for early-stage disease
Different surgical approaches depending on tumor location and stage
May be minimally invasive when appropriate

Chemotherapy

Common regimens include: • FOLFOX (5-FU, leucovorin, and oxaliplatin) • FOLFIRI (5-FU, leucovorin, and irinotecan) • CAPOX (capecitabine and oxaliplatin)

Targeted Therapy The American Society of Clinical Oncology (ASCO) Guidelines highlight several targeted treatments:

EGFR inhibitors (cetuximab, panitumumab) for RAS wild-type tumors
VEGF inhibitors (bevacizumab)
BRAF inhibitors for BRAF V600E mutations

Immunotherapy The National Cancer Institute (NCI) recognizes immunotherapy as an important option:

Checkpoint inhibitors for MSI-H/dMMR tumors
Pembrolizumab and nivolumab are FDA-approved for specific cases

Important notes:

Treatment plans are highly individualized based on: • Cancer stage • Tumor location • Genetic/molecular testing results • Overall health • Personal preferences

Always remember that your specific treatment plan should be determined by your healthcare team, as they can take into account your individual circumstances and medical history.

Would you like me to explain any of these treatment options in more detail?

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →